TDO2 and prostate carcinoma: Mechanistic studies of GR overexpression indicate that GR expression per se is subject to negative AR regulation49, as AR binds to an intronic enhancer of GR and directly represses GR expression in a subpopulation of prostate cancer cells50, similar to TDO2 regulation in this study.